Adicet Bio 13D/A Filed by Investor Group: SEC Form 13D/A (Apr 10, 2026) discloses a 8.9% stake (2.75M shares) in Adicet Bio, signaling heightened governance and strategic pressure for the clinical-stage biotech. 👈 Read full analysis #AdicetBio #Investing #Biotech #ClinicalStage #InvestorGroup
Adicet Bio 13D/A Filed by Investor Group
SEC Form 13D/A (Apr 10, 2026) discloses a 8.9% stake (2.75M shares) in Adicet Bio, signaling heightened governance and strategic pressure for the clinical-stage biotech.
dlvr.it
April 11, 2026 at 1:23 AM
Adicet Bio 13D/A Filed by Investor Group: SEC Form 13D/A (Apr 10, 2026) discloses a 8.9% stake (2.75M shares) in Adicet Bio, signaling heightened governance and strategic pressure for the clinical-stage biotech. 👈 Read full analysis #AdicetBio #Investing #Biotech #ClinicalStage #InvestorGroup
GeoVax Labs (GOVX) announces a warrant inducement deal generating ~$3.6M in gross proceeds to support its mpox vaccine and oncology pipeline. New warrants covering 11.4M shares issued to institutional investor at $0.64 per share. #Biotech #ClinicalStage
August 27, 2026 at 8:13 AM
GeoVax Labs (GOVX) announces a warrant inducement deal generating ~$3.6M in gross proceeds to support its mpox vaccine and oncology pipeline. New warrants covering 11.4M shares issued to institutional investor at $0.64 per share. #Biotech #ClinicalStage